| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000267136.1 |
Gefitinib |
Cervical squamouscell carcinoma and endocervical adenocarcinoma |
0.022756297 |
Resistant |
| ENSG00000267136.1 |
Gefitinib |
Chronic Lymphocytic Leukemia |
0.032633187 |
Resistant |
| ENSG00000267136.1 |
Gefitinib |
Lung squamous cell carcinoma |
0.024180863 |
Resistant |
